For research purposes only. This compound is not FDA approved. All data presented is from clinical trials for educational reference.
Research Use Only
Blends
CJC-1295 / Ipamorelin (No DAC) 5mg/5mg
blendcjc-1295ipamorelinresearchpopularbest-seller
A strategic peptide combination engineered to enhance gh release through synchronized GHRH and ghrelin receptor activation in experimental research models. Premium Research Peptide.
Dosage
$69.995MG
In Stock
5XEarn 349 points (5x points) with a free account
Add $80.01 more to save 8% off
Product Details
CJC-1295 / Ipamorelin Blend
CJC-1295 / Ipamorelin is a precision-formulated research peptide blend combining CJC-1295 (no DAC) (5mg) and Ipamorelin (5mg) in a single vial. Each vial contains 10mg total of lyophilized peptide blend for research purposes only. Third-party 7x tested with Certificate of Analysis (COA) available. Purity: >99%. COA Batch: MPCJP001.
Description
This blend combines two well-characterized peptides frequently utilized in laboratory settings to explore growth hormone secretagogue pathways:
- CJC-1295 (w/o DAC) is a tetrasubstituted peptide analogue of growth hormone–releasing hormone (GHRH). The "without DAC" modification provides a shorter half-life, allowing study of pulsatile GH release models.
- Ipamorelin is a selective ghrelin receptor agonist studied for its ability to stimulate GH release in vitro without significantly affecting prolactin or cortisol pathways.
Together, this blend offers researchers a complementary model system for investigating GH-related signaling and cellular responses.
Specifications
- Form: Lyophilized powder
- Unit Size: 10mg total (5mg CJC-1295 w/o DAC + 5mg Ipamorelin per vial)
- Storage: Store lyophilized at –20°C. After reconstitution, refrigerate at 2–8°C. Protect from light and moisture.
Application Context
CJC-1295 (w/o DAC) + Ipamorelin is studied in vitro for potential roles in:
- Growth hormone secretagogue pathway modeling
- Pulsatile GH release vs. extended half-life analogues
- Ghrelin receptor agonist selectivity and activity
- Synergistic peptide interactions on pituitary cell assays
- Comparative peptide pharmacology research
Intended Use
This compound is intended strictly for in vitro laboratory research. It is not approved for human or animal consumption and must not be incorporated into food, drugs, supplements, or cosmetics.
Legal Disclaimer
This product and all related information have not been evaluated by the U.S. Food and Drug Administration. No claims are made regarding diagnosis, treatment, cure, or prevention of disease. Use is limited to qualified research professionals in certified laboratory environments.
Terms of Sale
By purchasing from Midwest Peptide, the buyer affirms they are a qualified researcher or institution. The purchaser assumes full responsibility for lawful handling, storage, and application of this material. All sales are final.
Frequently Asked Questions
What is the CJC-1295 / Ipamorelin blend?
+
This research peptide blend combines CJC-1295 (a long-acting GHRH analog) with ipamorelin (a selective ghrelin / GHS-R1a receptor agonist). In research models the two molecules act on parallel pathways of the growth hormone axis. Supplied strictly for Research Use Only.
Is this CJC-1295 with DAC or without DAC?
+
This blend contains CJC-1295 without DAC (no Drug Affinity Complex moiety). Without-DAC CJC-1295 has a shorter circulating half-life than the DAC-modified variant, producing a more pulsatile profile in research models that aligns with co-administration of a GHRP like ipamorelin.
Why are CJC-1295 and ipamorelin studied together?
+
CJC-1295 stimulates pituitary GH release via the GHRH receptor while ipamorelin stimulates the same cells via the GHS-R1a (ghrelin) receptor. Research models show the combined GHRH+GHRP mechanism produces a synergistic GH pulse that neither molecule produces alone.
What is this blend used for in research?
+
Related Products
Other research peptides in this category
Important Research Notice
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
